Articles published by Teva Pharmaceutical Industries Ltd
Teva Prolia® (Denosumab) Biosimilar Candidate is Accepted for Review by U.S. FDA and EU EMA
October 08, 2024
Via GlobeNewswire
Tickers
TEVA
Via GlobeNewswire
Tickers
TEVA
Teva to Present at the Bank of America 2024 Global Healthcare Conference
September 11, 2024
Via GlobeNewswire
Tickers
TEVA
Via GlobeNewswire
Tickers
TEVA
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|